Latest filing published 16 Jun 2017 for ALEXION PHARMACEUTICALS INC, €87k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alvin S. Parven: trading record in brief
Alvin S. Parven is a declared insider of Alexion Pharmaceuticals Inc, with filings sourced from SEC (Form 4). The record holds 153 filings, for trades running from 9 January 2006 to 15 June 2017.
Both buying and selling appear: 1 purchase worth €9,019, against 64 sales worth €18.3M. Sales outweigh purchases by €18.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 10 share grants and 67 option exercises. 2017 to date brings no purchases and 16 sales.
The record was last updated on 16 June 2017 with an open-market sale (€87k) in Alexion Pharmaceuticals Inc. The most recent open-market purchase was published on 11 December 2013, 4,715 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alvin S. Parven
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 835 shares@ US$116.781.4% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000142:0
- 2,030 shares0Common Stock, par value $.0001 per shareSEC:0000899866-17-000115:0
- 7,932 shares@ US$26.643.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:0
- 5,572 shares@ US$49.434.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:1
- 3,237 shares@ US$85.754.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:2
- 3,425 shares@ US$96.355.0% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:3
- 185 shares@ US$133.950.4% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:4
- 369 shares@ US$135.700.8% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:5
- 7,375 shares@ US$137.5615.5% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:6
- 5,176 shares@ US$138.6010.9% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:7
- 5,350 shares@ US$139.4911.4% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:8
- 1,433 shares@ US$140.593.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:9
- 278 shares@ US$141.230.6% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:10
- 853 shares@ US$133.651.7% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:11
- 15 shares@ US$133.950.0% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:12
- 31 shares@ US$135.690.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:13
- 599 shares@ US$137.561.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:14
- 421 shares@ US$138.600.9% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:15
- 435 shares@ US$139.490.9% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:16
- 117 shares@ US$140.590.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:17
- 22 shares@ US$141.220.0% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000008:18
- 700 shares@ US$135.511.4% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000345:0
- 15,000 shares@ US$18.013.8% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000345:1
- 15,000 shares@ US$136.5329.0% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000345:2
- 835 shares0Common Stock, par value $.0001 per shareSEC:0000899866-16-000301:0
25 of 146 declarations
